An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination

被引:5
|
作者
Yoshimura, Yukihiro [1 ]
Sasaki, Hiroaki [1 ]
Miyata, Nobuyuki [1 ]
Miyazaki, Kazuhito [2 ]
Okudela, Koji [3 ]
Tateishi, Yoko [4 ]
Hayashi, Hiroyuki [4 ]
Kawana-Tachikawa, Ai [5 ]
Iwashita, Hiromichi [3 ]
Maeda, Kazuho [6 ]
Ihama, Yoko [6 ]
Hatayama, Yasuyoshi [7 ]
Ryo, Akihide [7 ]
Tachikawa, Natsuo [1 ]
机构
[1] Yokohama Municipal Citizens Hosp, Dept Infect Dis, Yokohama, Kanagawa, Japan
[2] Yokohama Municipal Citizens Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan
[3] Yokohama City Univ, Dept Pathol, Grad Sch Med, Yokohama, Kanagawa, Japan
[4] Yokohama Municipal Citizens Hosp, Dept Pathol, Yokohama, Kanagawa, Japan
[5] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan
[6] Yokohama City Univ, Dept Legal Med, Grad Sch Med, Yokohama, Kanagawa, Japan
[7] Yokohama City Univ, Dept Microbiol, Sch Med, Yokohama, Kanagawa, Japan
关键词
COVID-19; vaccine; acute respiratory distress syndrome; autopsy;
D O I
10.1016/j.ijid.2022.04.057
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We report the first case with COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination. An 88-year-old woman developed dyspnea several hours after vaccination with the second dose of mRNA-1273. She was hospitalized on day nine due to worsening dyspnea. Chest computed tomography showed bilateral ground-glass opacities and consolidations, mainly in the peripheral lung areas. Repeat polymerase chain reaction tests for SARS-CoV-2 were negative, although the serum level of antibodies against spike protein was extremely elevated. Her condition did not improve with high-dose corticosteroids and high-flow nasal cannula oxygen therapy; she died on day 18. Autopsy findings revealed very early-phase diffuse alveolar damage in the whole lung without other lung diseases. The clinical and pathological findings suggested vaccine-induced acute respiratory distress syndrome. Serological and pathological tests might be useful to differentiate the disease from COVID-19. (C) 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:98 / 101
页数:4
相关论文
共 50 条
  • [1] Acute myocarditis after COVID-19 vaccination with mRNA-1273 in a patient with former SARS-CoV-2 infection
    Nguyen, Tien Dung
    Mall, Gerhard
    Westphal, Julian Georg
    Weingaertner, Oliver
    Moebius-Winkler, Sven
    Schulze, Paul Christian
    ESC HEART FAILURE, 2022, 8 (06): : 4710 - 4714
  • [2] Acute myocarditis after COVID-19 vaccination with mRNA-1273 in a patient with former SARS-CoV-2 infection
    Nguyen, Tien Dung
    Mall, Gerhard
    Westphal, Julian Georg
    Weingaertner, Oliver
    Moebius-Winkler, Sven
    Schulze, Paul Christian
    ESC HEART FAILURE, 2021, 8 (06): : 4710 - 4714
  • [3] Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
    Widge, Alicia T.
    Rouphael, Nadine G.
    Jackson, Lisa A.
    Anderson, Evan J.
    Roberts, Paul C.
    Makhene, Mamodikoe
    Chappell, James D.
    Denison, Mark R.
    Stevens, Laura J.
    Pruijssers, Andrea J.
    McDermott, Adrian B.
    Flach, Britta
    Lin, Bob C.
    Doria-Rose, Nicole A.
    O'Dell, Sijy
    Schmidt, Stephen D.
    Neuzil, Kathleen M.
    Bennett, Hamilton
    Leav, Brett
    Makowski, Mat
    Albert, Jim
    Cross, Kaitlyn
    Edara, Venkata-Viswanadh
    Floyd, Katharine
    Suthar, Mehul S.
    Buchanan, Wendy
    Luke, Catherine J.
    Ledgerwood, Julie E.
    Mascola, John R.
    Graham, Barney S.
    Beigel, John H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (01): : 80 - +
  • [4] Acute Myocarditis in a Patient Following mRNA-1273 SARS-CoV-2 Vaccination
    Kawakami, Toshinaru
    Yahagi, Kazuyuki
    Sekiguchi, Masahiro
    Ishizawa, Taiki
    Nonaka, Hideaki
    Setoguchi, Naoto
    Watanabe, Yusuke
    Nakase, Masaaki
    Horiuchi, Yu
    Asami, Masahiko
    Yuzawa, Hitomi
    Komiyama, Kota
    Tanaka, Jun
    Aoki, Jiro
    Tanabe, Kengo
    INTERNAL MEDICINE, 2022, 61 (09) : 1371 - 1374
  • [5] Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination
    Maki, Hisataka
    Aikawa, Tadao
    Ibe, Tatsuro
    Oyama-Manabe, Noriko
    Fujita, Hideo
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2022, 23 (02) : E87 - E87
  • [6] Membranous nephropathy following SARS-CoV-2 mRNA-1273 vaccination
    Vongchaiudomchoke, Thanawat
    Cheunsuchon, Boonyarit
    Noppakun, Kajohnsak
    MEDICINA CLINICA, 2023, 161 (11): : 504 - 505
  • [7] Atrial Fibrillation After mRNA-1273 SARS-CoV-2 Vaccination: Case Report with Literature Review
    Chen, Chao-Yang
    Hsieh, Ming-Ta
    Wei, Chen-Ting
    Lin, Chi-Wei
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2023, 16 : 209 - 214
  • [8] SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
    Qi, Xian
    Qiu, Haibo
    Bao, Changjun
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (11):
  • [9] Case report: SARS-CoV-2 specific T-cells are associated with myocarditis after COVID-19 vaccination with mRNA-1273
    Stervbo, Ulrik
    Van Bracht, Marc
    Philippou, Stathis
    Babel, Nina
    Westhoff, Timm H.
    FRONTIERS IN MEDICINE, 2023, 10
  • [10] Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination
    Shen, Xiaoying
    Chalkias, Spyros
    Feng, Jing
    Chen, Xing
    Zhou, Honghong
    Marshall, Jean-Claude
    Girard, Bethany
    Tomassini, Joanne E.
    Aunins, Anne
    Das, Rituparna
    Montefiori, David C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (13): : 1234 - 1236